Iovance Biotherapeutics (IOVA)
(Delayed Data from NSDQ)
$10.34 USD
+0.88 (9.30%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $10.34 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
Iovance Biotherapeutics, Inc. [IOVA]
Reports for Purchase
Showing records 181 - 193 ( 193 total )
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
On the Road to Takeout; Profiling Continued Differentiation vs. CAR-T; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Nice Early Peek as the Plan Is Starting to Come Together; Target Boosted to $22
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Regulatory Visibility and Hopefully Game Changing Data for Solid Tumors in 2018
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
2018 and TILs Should Strike a Nice Pose; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
SITC Provides Some Real Answers for Important Upcoming Discussions; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Initial Gen 2 Look Points In Right Direction for Process and Efficacy; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
3Q17 Results; Second Star to the Right and Straight on TIL Morning; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Shout Out to WuXi; Iovance in Good Hands; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Targeting Liquid Tumors and Automating the Supply Chain; Iovance Expanding on Multiple Fronts
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Pins Set Up: Kite Acquired and Kymriah Approved; TILs Can Knock ''Em Down; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Cervical Study Gets Underway as Push Continues for Solid Tumor Differentiation; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
2Q17 Results; New Name but Still Roaring; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: Iovance Biotherapeutics, Inc.
Industry: Medical - Biomedical and Genetics
2Q17 Results; New Name but Still Roaring; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.